ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome

[1] Allan AL(2006)Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis Breast Dis 26 87-98

[2] Vantyghem SA(2008)Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression J Clin Oncol 26 3324-3330

[3] Tuck AB(2007)Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry Cancer 109 1721-1728

[4] Chambers AF(2009)ALDH1 expression correlates with favorable prognosis in ovarian cancers Mod Pathol 22 817-823

[5] Anders CK(2012)Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers Pathology 44 303-312

[6] Hsu DS(2007)Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 4429-4434

[7] Broadwater G(2006)Effects of young age at presentation on survival in breast cancer BMC Cancer 6 194-222

[8] Acharya CR(2006)Breast carcinoma in women 35 years and younger: a pathological study Pathology 38 219-567

[9] Foekens JA(2007)ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 555-373

[10] Zhang Y(2010)Markers of tumor-initiating cells predict chemoresistance in breast cancer PLoS One 5 e15630-1281

[1] Allan AL(2006)Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis Breast Dis 26 87-98

[2] Vantyghem SA(2008)Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression J Clin Oncol 26 3324-3330

[3] Tuck AB(2007)Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry Cancer 109 1721-1728

[4] Chambers AF(2009)ALDH1 expression correlates with favorable prognosis in ovarian cancers Mod Pathol 22 817-823

[5] Anders CK(2012)Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers Pathology 44 303-312

[6] Hsu DS(2007)Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 4429-4434

[7] Broadwater G(2006)Effects of young age at presentation on survival in breast cancer BMC Cancer 6 194-222

[8] Acharya CR(2006)Breast carcinoma in women 35 years and younger: a pathological study Pathology 38 219-567

[9] Foekens JA(2007)ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 555-373

[10] Zhang Y(2010)Markers of tumor-initiating cells predict chemoresistance in breast cancer PLoS One 5 e15630-1281